Trial intelligence / Profile preview

Recombinant Hepatitis B Vaccines With and Without Adjuvant in Healthy Older Adults

NCT00697242Phase 3Completed

Sponsor
GSK
Start
Jan 1994
Primary completion
Nov 1995
Modality
Vaccines & Immunotherapeutics
Countries
4
01

Overview

A Phase 3 trial of hepatitis b vaccine recombinant in hepatitis B (HBV), sponsored by GSK. Started Jan 1994; status: completed.

02

Drugs

hepatitis b vaccine recombinant
03

Conditions

hepatitis B (HBV)

Beyond the preview

Go deeper on NCT00697242.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00697242.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call